As fresh evidence mounts that preventive measures produce a considerable decrease in the incidence of primary and secondary cardiac events and mortality, there is growing understanding that health care providers must initiate preventive strategies in the management and care of their patients. In Preventive Cardiology: Strategies for the Prevention and Treatment of Coronary Artery Disease, leading clinicians and researchers-many internationally recognized in their area of research-concisely review the significant risk factors, including dyslipidemias, hypertension, diabetes, lack of exercise, obesity, tobacco, and homocysteine, and outline the best preventive strategies available. They also offer an overview of the new paradigms in coronary artery disease pathology, including the nature of the unstable atherosclerotic plaque, new strategies for the modification of plaque constituents, the importance of the endothelium in the maintenance of cardiovascular health, and the emerging roles of oxidative stress, infection, and inflammation. Among the particular strategies discussed in detail are pharmacologic therapies, aspirin and antiplatelet agents, exercise testing for identifying at-risk patients, and the possibilities of electron beam tomography.
Comprehensive and pathbreaking, Preventive Cardiology: Strategies for the Prevention and Treatment of Coronary Artery Disease provides physicians with the understanding and tools necessary to bring the practice of prevention to their patients.

Klappentext

Leading clinicians and researchers concisely review the significant risk factors, including dyslipidemias, hypertension, diabetes, lack of exercise, obesity, tobacco, and homocysteine, and outline the best preventive strategies available. They also offer an overview of the new paradigms in coronary artery disease pathophysiology, including the nature of the unstable atherosclerotic plaque, new strategies for the modification of plaque constituents, the importance of the endothelium in the maintenance of cardiovascular health, and the emerging roles of oxidative stress, infection, and inflammation. Comprehensive and pathbreaking, Preventive Cardiology: Strategies for the Prevention and Treatment of Coronary Artery Disease provides physicians with the understanding and tools necessary to bring the practice of preventive cardiology to their patients.

Inhalt

Part I. New Paradigms in the Pathophysiology of Coronary Artery Disease. The Unstable Plaque: Implications and Opportunities for Prevention, JoAnne Micale Foody, md, and Steven E. Nissen, md. Endothelial Function and Insights for Prevention, Eric H. Lieberman, md, Margarita R. Garces, md, and Francisco Lopez-Jimenez, md, msc. Role of Antioxidants in Coronary Artery Disease, R. Preston Mason, phd. Inflammation and Infection in Coronary Artery Disease, Michael A. Lauer, md. Part II. Risk Factors and Their Management in Coronary Artery Disease. Dyslipidemias and Coronary Artery Disease: Clinical Evidence and Clinical Implications, JoAnne Micale Foody, md. Management of Hypertension: Implications of JNC VI, Donald G. Vidt, md. Diabetes Mellitus, Hyperinsulinemia, and Coronary Artery Disease, Byron J. Hoogwerf, md. Exercise in the Prevention of Coronary Artery Disease, Gordon G. Blackburn, phd. Obesity and Coronary Artery Disease: Implications and Interventions, Kristine Napier, mph, rd. Tobacco as a Cardiovascular Risk Factor, Robyn Bergman Buchsbaum, nhs, ches, and Jeffrey Craig Buchsbaum, md, phd. Women and Coronary Artery Disease, JoAnne Micale Foody, md, and Cynthia Pordon, do. A Recognized Risk Factor: Homocysteine and Coronary Artery Disease, Simone Nader, md, and Killian Robinson, md. Part III. Strategies for Prevention. Pharmacologic Agents in Preventive Cardiology, Michael A. Militello, pharmd and Teresa H. Seo, pharmd. Aspirin and Antiplatelet Agents in the Prevention of Complications of Coronary Artery Disease, Scott A. Moore, md, and Steve R. Steinhubl, md. Exercise Testing and Risk Assessment, Christopher R. Cole, md, and Michael S. Lauer, md. Electron Beam Tomography in the Prevention of Coronary Artery Disease, Arthur Agatston, md. A Multidisciplinary Model for Aggressive Risk Factor Control in Cardiovascular Disease, Joseph P. Frolkis, md, phd. Pharmacoeconomics of Cardiovascular Medicine, Melanie Oates, phd, mba, rn, William F. McGhan, pharmd, phd, andRon Corey, phd, mba, rph. Index.